Mark Klang

6PUBLICATIONS
32CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Nanofabrication, growth and self assembly
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 02, 2026
Critical role of keratinocytes and protease-activated receptor 2 in secondary lymphedema development.

|Nov 06, 2023
Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and Trametinib.

Paul B Chapman, Mark Klang, Michael A Postow

|Feb 27, 2023
Developing guidance for feeding tube administration of oral medications.

Mark G Klang

|Jun 02, 2022
TGF-β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation.

Jung Eun Baik, Hyeung Ju Park, Raghu P Kataru

|Oct 13, 2020
Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors.

Filip Janku, Halle Huihong Zhang, Abdulmohammad Pezeshki

Pageof 1

Frequent Collaborators

2 joint publications

Hyeung Ju Park

1 joint publications

Suzie Ferrie

1 joint publications

Sarit Pal

1 joint publications

Xizhao Chen